Left ventricular hypertrophy and its regression: Pathophysiology and therapeutic approach: Focus on treatment by antihypertensive agents

American Journal of Hypertension

Volumn 11, Issue 11 I, 1998, Pages 1394-1404

  Schlaich, Markus P ^a   Schmieder, Roland E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

blockers; Angiotensin converting enzyme inhibitors; Antihypertensive drug; Calcium channel blockers; Cardiovascular risk; Diuretics; Left ventricular hypertrophy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO;

CARDIOVASCULAR RISK; CLINICAL TRIAL; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; META ANALYSIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; REVIEW; RISK FACTOR;

ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; PREVALENCE; PROGNOSIS;

EID: 0031795155     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00149-6     Document Type: Review

References (90)

1. Levy D., Garrison R.J., Savage D.D., et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 322:1990;1561-1566.
2. Koren M.J., Devereux R.B., Casale P.N., et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Int Med. 114:1991;345-352.
3. Hammond I.W., Devereux R.B., Alderman M.H., Laragh J.H. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. J Am Coll Cardiol. 12:1988;994-1004.
4. Kannel W.B. Left ventricular hypertrophy as a risk factor the Framingham experience . J Hypertens. 9:(suppl):1991;S3-S9.
5. Lauer M., Anderson K.M., Kannel W.B., Levy D. The impact of obesity on left ventricular mass and geometry. JAMA. 266:1991;231-236.
6. Schmieder R.E., Messerli F.H. Does obesity influence early target organ damage in hypertensive patients? Circulation. 87:1993;1482-1488.
7. Liebson P.R., Grandits G., Prineas R. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 87:1993;476-486.
8. Levy D., Anderson K.M., Savage D.D., Kannel W.B., Christiansen J.C., Castelli W.P. Echocardiographically detected left ventricular hypertrophy prevalence and risk factors . Ann Intern Med. 108:1988;7-13.
9. Laufer E., Jennings G.L., Korner P.I., Dewar E. Prevalence of cardiac structural and functional abnormalities in untreated primary hypertension. Hypertension. 13:1989;151-162.
10. Messerli F.H., Sundgaard Riise K., Reisen E.D. Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med. 99:1983;757-761.
11. Shapiro L.M., MacKinnon J., Beevers D.G. Echocardiographic features of of malignant hypertension. Br Heart J. 46:1981;374-379.
12. Thompson J.A., Hays P.M., Sagar K.B., Cruickshank D.P. Echocardiographic left ventricular mass to differentiate chronic hypertension from pre-eclampsia during pregnancy. Am J Obstet Gynecol. 155:1986;994-999.
13. Vensel L.A., Devereux R.B., Pickering T.G., et al. Cardiac anatomy and function in renovascular hypertension produced by unilateral and bilateral renal artery stenosis. Am J Cardiol. 58:1986;575-582.
14. Fouad-Tarazi F.M., Imamura M., Bravo L. Differences in left ventricular structural and functional changes between pheochromocytoma and essential hypertension. Am J Hypertens. 5:1992;134-140.
15. Aronow W.S., Kronzon I. Prevalence of coronary risk factors in elderly blacks and whites. J Am Geriatr Soc. 39:1991;567-570.
16. Schmieder R.E., Messerli F.H., Garavaglia G.E., Nunez B.D. Dietary salt intake. A determinant of cardiac involvement in essential hypertension. Circulation. 78:1988;951-956.
17. Silberberg J.S., Rahak D.P., Patton D.R., Sniderman A.D. Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease. Am J Cardiol. 64:1989;222-224.
18. Manolio T.A., Levy D., Garrison R.J., et al. Relation of alcohol intake to left ventricular mass the Framingham Study . J Am Coll Cardiol. 17:1991;717-721.
19. Garavaglia G.E., Messerli F.H., Schmieder R.E., et al. Sex differences in cardiac adaptation to essential hypertension. Eur Heart J. 10:1989;1110-1114.
20. Kupari M., Koskinen P., Virolainen J. Correlates of left ventricular mass in a population sample aged 36 to 37 years. Circulation. 89:1994;1041-1050.
21. Casale P.N., Devereux R.B., Milner M., et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 105:1986;173-178.
22. Silberberg J.S., Barre P., Prichard S., Sniderman A.D. Left ventricular hypertrophy an independent determinant of survival in endstage renal failure . Kidney Int. 36:1989;286-290.
23. Parfrey P.S., Harnett J.D., Griffiths S.M., et al. The clinical course of left ventricular hypertrophy in dialysis patients. Nephron. 55:1990;114-120.
24. Foley R.N., Parfrey P.S., Harnett J.D., et al. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol. 5:1995;2024-2031.
25. Ghali J.K., Liao Y., Simmons B., et al. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Int Med. 117:1992;831-836.
26. Aronow W.S., Königsberg M., Schwartz K.S. Usefulness of echocariographic left ventricular hypertrophy in predicting new coronary events and atherothrombotic brain infarction in patients over 62 years of age. Am J Cardiol. 621:1988;1130-1132.
27. Aronow W.S., Ahn C., Kronzon K. I, önigsberg M. Congestive heart failure, coronary events, and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without electrocardiographic evidence of left ventricular hypertrophy. Am J Cardiol. 67:1991;295-299.
28. Lima J.A.C., Gerstenblith G., Weiss J.L., et al. Systolic blood pressure, not age, mediates the age-related increase in left ventricular wall thickness within a normotensive population (abs). J Am Coll Cardiol. 11:1988;81A.
29. Devereux R.B., Pickering T.G., Harshfield G.A., et al. Left ventricular hypertrophy in patients with hypertension importance of blood pressure responses to regularly recurring stress . Circulation. 68:1983;470-476.
30. Prisant L.M., Carr A.A. Ambulatory blood pressure monitoring and echocardiographic left ventricular wall thickness in man. Am J Hypertens. 3:1990;81-89.
31. Ravogli A., Trazzi S., Villani A., et al. Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension. Hypertension. 16:1990;491-497.
32. Ganau A., Devereux R.B., Pickering T.G., et al. Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation. 81:1990;21-36.
33. Devereux R.B., Savage D.D., Sachs I., Laragh J.H. Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension. Am J Cardiol. 51:1983;171-176.
34. Aronow W.S., Kronzon I. Prevalence and severity of valvular aortic stenosis determined by Doppler echocardiography and its association with echocardiographic and electrocardiographic left ventricular hypertrophy and physical signs of aortic stenosis in elderly patients. Am J Cardiol. 67:1991;776-777.
35. Roman M.J., Klein L., Devereux R.B., et al. Reversal of left ventricular dilation, hypertrophy, and dysfunction by valve replacement in aortic regurgitation. Am Heart J. 118:1989;553-563.
36. Roman M.J., Saba P.S., Pini R., et al. Parallel cardiac and vascular adaptation in hypertension. Circulation. 86:1992;1909-1918.
37. Devereux R.B., Drayer J.I.M., Chien S., et al. Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension. Am J Cardiol. 54:1984;592-595.
38. DeSimone G., Devereux R.B., Roman M.J., et al. Gender differences in left ventricular anatomy, blood viscosity, and volume regulatory hormones in normal adults. Am J Cardiol. 68:1991;1704-1708.
39. Boden W.E., Kleiger R.E., Schechtman K.B., et al. Clinical significance and prognostic importance of left ventricular hypertrophy in non-Q-wave acute myocardial infarction. Am J Cardiol. 62:1988;1000-1004.
40. Cooper R.S., Simmons B.E., Castaner A., et al. Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed. Am J Cardiol. 65:1990;441-445.
41. Aronow W.S., Epstein S., Königsberg M., Schwartz K.S. Usefulness of echocardiographic left ventricular hypertrophy, ventricular tachycardia and complex ventricular arrhythmias in predicting ventricular fibrillation or sudden cardiac death in elderly patients. Am J Cardiol. 62:1988;1124-1125.
42. Alderman E.L., Harrison D.C. Myocardial hypertrophy resulting from low dose isoproterenol administration in rats. Proc Soc Exp Biol Med. 136:1970;268-270.
43. Laks M.M., Morady F., Swan H.J.C. Myocardial hypertrophy produced by chronic infusion of subhypertensive doese of norepinephrine in the dog. Chest. 64:1973;75-78.
44. Mann D.L., Kent R.L., Parsons B., Cooper G. IV. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 85:1992;790-804.
45. Everett A.D., Tufro-McReddie A., Fisher A., Gomez A. Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-β1 expression. Hypertension. 23:1994;587-592.
46. Nagano M., Higaki J., Mikami H., et al. Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats. J Hypertens. 9:1991;595-599.
47. Schmieder R.E., Messerli F.H., Garavaglia G.E., Nunez B. Does the renin-angiotensin-aldosterone system modify cardiac structure and function in essential hypertension? Am J Med. 84:(suppl 3A):1988;136-139.
48. Schmieder R.E., Langenfeld M.R.W., Friedrich A., et al. Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. Circulation. 94:1996;1304-1309.
49. Schlaich M.P., Schobel H., Langenfeld M.R.W., Hilgers K., Schmieder R.E. Inadequate suppression of angiotensin II modulates left ventricular structure in humans. Clin Nephrol. 49:1998;153-159.
50. ACE inhibitor ramipril is more effective than the β-blocker atenolol in reducing left ventricular mass in hypertension results of the RACE (Ramipril Cardioprotective Evaluation) Study . J Hypertens. 12:1995;1325-1334.
51. Garavaglia G.E., Messerli F.H., Nunez B.D., et al. Angiotensin-converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect. Am J Hypertens. 1:1988;214S-216S.
52. Brilla C.G., Pick R., Tan L.B., et al. Remodelling of the rat right and left ventricles in experimental hypertension. Circ Res. 67:1990;1355-1364.
53. Brilla C.G., Weber K.T. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovasc Res. 26:1992;671-677.
54. Schlaich M.P., Schobel H., Hilgers K., Gatzka C.D., Schmieder R.E. Aldosterone affects left ventricular structure and function in essential hypertension. Am J Hypertens. 10:1997;28A.
55. Harshfield G.A., Grim C.E., Hwang C., et al. Genetic and environmental influences on echocardiographically determined left ventricular mass in black twins. Am J Hypertens. 3:1990;538-543.
56. Verhaaren H.A., Schieken R.M., Mosteller M., et al. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins. Am J Cardiol. 68:1991;661-668.
57. Dunn F.G., Oigman W., Sungaard-Riise K., et al. Racial differences in cardiac adaptation to essential hypertension determined by echocardiographic indexes. J Am Coll Cardiol. 1:1983;1348-1351.
58. Koren M.J., Mensah G.A., Blaje J., et al. Comparison of left ventricular mass and geometry in black and white patients with essential hypertension. Am J Hypertens. 6:1993;815-823.
59. Jennings G., Dart A., Meredith I., et al. Effects of exercise and other non-pharmacologic measures on blood pressure and cardiac hypertrophy. J Cardiovasc Pharmacol. 17:(suppl 2):1991;S70-S74.
60. MacMahon S.W., McDonald G.J., Bernstein L., et al. Comparison of weight reduction with metoprolol and treatment of hypertension in young overweight patients. Lancet. i:1986;1233-1236.
61. MacMahon S.W., Wilcken D.E.L., McDonald G.J. The effect of weight reduction on left ventricular mass a randomized controlled trial in young, overweight hypertensive patients . N Engl J Med. 314:1986;334-339.
62. Liebson P.R., Grandits T.A., Dianzumba S., et al. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 91:1995;698-706.
63. Ferrara L.A., DeSimone G., Pasanisi F., et al. Left ventricular mass reduction during salt depletion in arterial hypertension. Hypertension. 6:1984;755-759.
64. Neaton J.D., Grimm R.H., Prieas R.J., et al. Treatment of Mild Hypertension Study. Final results. JAMA. 270:1993;713-724.
65. Kelemen M.H., Effron M.B., Valenti S.A., Stewart K.J. Exercise training combined with antihypertensive drug therapy. Effects on lipids, blood pressure and left ventricular mass. JAMA. 263:1990;2766-2771.
66. Senior R., Imbs J.L., Bory M., et al. Indapamide reduces hypertensive left ventricular hypertrophy an international multicenter study . J Cardiovasc Pharmacol. 22:(suppl 6):1993;S106-S110.
67. Gottdiener J.S. Hypertensive heart disease in blacks. Cardiovasc Clin. 21:1991;133-134.
68. Gottdiener J.S., Reda D.J., Massie B.M., et al. Effect of single drug therapy on reduction of left ventricular mass in mild to moderate hypertension. Circulation. 95:1997;2007-2014.
69. Schobel H.P., Langenfeld M.R.W., Gatzka C.D., Schmieder R.E. Treatment and post-treatment effects of alpha- versus beta-receptor blockers on left ventricular structure and function in essential hypertension. Am Heart J. 132:1996;1004-1009.
70. Sacks H.S., Berrier J., Reitman D., et al. Meta-analyses of randomized controlled trials. N Engl M Med. 316:1987;450-455.
71. Dahlöf B., Pennert K., Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients a meta-analysis of 109 treatment studies . Am J Hypertens. 5:1992;95-110.
72. Cruickshank J., Lewis J., Moore E.V., Dodd C. Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens. 6:1992;85-90.
73. Schmieder R.E., Martus P., Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension a meta-analysis of randomized double-blind studies . JAMA. 275:1996;1507-1513.
74. Schmieder R.E., Schlaich M.P., Klingbeil A., Martus P. Reversal of left ventricular hypertrophy in essential hypertension: a meta-analysis of randomized double-blind studies. An update including studies until the end of December 1996. Nephrol Dial Transplant. 13:1998;564-569.
75. Galderisi M., Celentano A., Garofalo M., et al. Reduction of left ventricular mass by short term antihypertensive treatment with isradipine a double-blind comparison with enalapril . Int J Clin Pharmacol Ther. 32:1994;312-316.
76. Wambach G., Grimm U., Jacob R. Influence of the cardioselective betablockers celiprolol and atenolol on 24-h-blood pressure and left ventricular hypertrophy. Nieren- Hochdruckkr. 23:1994;167-169.
77. Chen C.H., Ting C.H., Lin S.J., et al. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension. 25:1995;1034-1041.
78. Dey H.M., Soufer R., Hoffer P., et al. Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension. Am J Hypertens. 9:1996;598-606.
79. Fogari R., Zoppi A., Mugellini A., et al. Effects of lisinopril vs hydralazine on left ventricular hypertrophy and ambulatory blood pressure monitoring in essential hypertension. Eur Heart J. 16:1995;1120-1125.
80. Trenkwalder P., Dobrindt R., Aulehner R., Lydtin H. Antihypertensive treatment with felodipine but not with a diuretic reduces episodes of myocardial ischemia in elderly patients with hypertension. Eur Heart J. 15:1994;1673-1680.
81. Kan Y., Hong Z., Ming S. Effects of nitrendipine and captopril on the quality of life in hypertensives with left ventricular hypertrophy. Bull Hunan Med Univ. 20:1995;450-452.
82. Kirpzidis H.G., Papazachariou G.S. Comparative effects of fosinopril and nifedipine on regression of left ventricular hypertrophy in hypertensive patients a double-blind study . Cardiovasc Drugs Ther. 9:1995;141-143.
83. Middlemost S.J., Tager R., Davis J., Sareli P. Effectiveness of enelapril in combination with low-dose hydrochlorothiazide versus enalapril alone for mild to moderate systemic hypertension in black patients. Am J Cardiol. 73:1994;1092-1097.
84. Henderson R.J., Cranswick R.W., Hunyor S.N. Structural adaptation of the heart in borderline hypertensives in response to blood pressure lowering with captopril. J Hypertens. 12:1994;65-67.
85. Komsuoglu B., Göldeli Ö., Gacar N., et al. The effects of nitrendipine and verapamil on the index of left ventricular mass in elderly hypertensives with left ventricular hypertrophy. Tr J Med Sci. 21:1994;97-102.
86. Gonzalez-Juanatley J.R., Garcia-Acuna J.M., Calvo Gomez C., et al. Effect of verapamil and nitrendipine on left ventricular mass and function (systolic and diastolic) in arterial hypertension. Rev Esp Cardiol. 47:1994;375-383.
87. Koren M.J., Ulin R.J., Laragh J.H., Devereux R.B. Reduction of left ventricular mass during treatment of essential hypertension is associated with improved prognosis. Am J Hypertens. 4:1991;1A.
88. Yurenev A.P., Dyakonova H.G., Novikov I.D., et al. Management of essential hypertension in patients with different degrees of left ventricular hypertrophy multicenter trial . Am J Hypertens. 5:1992;182s-189s.
89. Muiesan M.L., Salvetti M., Rizzoni D., et al. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens. 13:1996;1091-1095.
90. Rockstroh J.K., Vogt-Ladner G., Neumayer H.H., et al. Blood pressure independent effects of nitrendipine on cardiac structur in patients after renal transplantation. Nephrol Dial Transplant. 12:1997;1441-1447.